Better Tests- Improving Diagnostic Accuracy and Prognostication in Interstitial Lung Diseases
Better Tests
2 other identifiers
observational
750
1 country
3
Brief Summary
Patients with interstitial lung diseases (ILD) suffer significant delays in obtaining a diagnosis, and objective evidence of support for immunosuppressive therapies, due to weaknesses in the diagnostic tests available in ILD clinics. This project will assess several non-invasive assessments, focusing on blood and breath based sampling, to identify candidate tests that may translate through to routine clinical use. The tests being assessed will be initially employed in Pigeon Fanciers, a group recognised to be at high risk of developing ILD compared to age matched controls, due to their regular exposure to a known cause of ILD. Candidate tests will also be assessed for change over time in this group. Tests which show promise will then be utilised in patients with ILD diagnoses, including those with severe respiratory failure, to assess their acceptability to patients and their ability to provide useful prognostic information, to allow powering of future definitive clinical trials.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2026
Longer than P75 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 17, 2026
CompletedFirst Submitted
Initial submission to the registry
May 22, 2026
CompletedFirst Posted
Study publicly available on registry
May 29, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2036
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 15, 2036
May 29, 2026
May 1, 2026
10 years
May 22, 2026
May 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Prediction of subsequent clinical outcomes
The utilised tests will be examined for their ability to accurately predict the subsequent diagnostic label for ILD and clinical behaviour
5 years
Acceptability to participants
The tests employed will be assessed for their ease of performance and acceptability from a participant perspective
5 years
Study Arms (3)
Pigeon Fanciers
Active Pigeon Fanciers
Clinic patients with ILD
Patients with established Interstitial Lung Disease attending clinic
Hospital patients with ILD
Patients with established Interstitial Lung Disease admitted due to their condition
Eligibility Criteria
Active Pigeon Fanciers, or patients with ILD presenting to clinics or hospital services with severe respiratory failure due to ILD
You may qualify if:
- To participate subjects will either have to be active Pigeon Fanciers, or will be either attending ILD clinics for management of their interstitial lung disease or will present acutely to hospital services with severe respiratory failure due to ILD.
You may not qualify if:
- Unable to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Dundeelead
- NHS Taysidecollaborator
- British Pigeon Fanciers Medical Researchcollaborator
Study Sites (3)
Winter Gardens
Blackpool, FY1 1HU, United Kingdom
Ninewells Hospital
Dundee, DD21UB, United Kingdom
Perth Royal Infirmary
Perth, PH1 1NX, United Kingdom
Biospecimen
Blood and breath samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mark Spears, PhD FRCP
NHS Tayside and University of Dundee
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant Respiratory Physician
Study Record Dates
First Submitted
May 22, 2026
First Posted
May 29, 2026
Study Start
January 17, 2026
Primary Completion (Estimated)
January 15, 2036
Study Completion (Estimated)
January 15, 2036
Last Updated
May 29, 2026
Record last verified: 2026-05